Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Trump administration approves generic version of abortion pill after RFK Jr had FDA review drug’s safety

The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’

The Independent UK

The Best Biotech ETFs to Buy

Biotech ETFs offer investors exposure to the most innovative and growth-oriented industry within the traditionally defensive healthcare sector.

Kiplinger

Conservatives rage after FDA approves generic abortion drug

The decision adds to conservative scrutiny of the agency and Commissioner Marty Makary.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

Top 2 Health Care Stocks That May Keep You Up At Night This Month

As of Oct. 2, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga

Mountain Dew, Gatorade and Cheetos to undergo makeover amid health fears

PepsiCo is looking at purple sweet potatoes and carrots to color drinks like Mountain Dew and Cherry 7Up

The Independent UK

The frozen fruit was sold in retailers across the U.S.

The Independent UK

Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?

Shares of Tempus AI Inc (NASDAQ:TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here’s what investors need to know.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions

Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing organization (GPO) agreements for its new drug, Arbli (losartan potassium) Oral Suspension, 10 mg/mL.

Benzinga

Walmart sets a timeline for removing synthetic dyes and other additives from its food brands

Walmart says it plans to remove synthetic dyes and 30 other food additives from its store brands sold in the United States by January 2027

The Independent UK

Federal agencies blame Democrats for looming shutdown in apparent Hatch Act violation

Housing and VA departments attack ‘radical left’ despite law limiting political activities of government employees

The Guardian - US

Can Americans Trust RFK Jr.'s Health Advice? A Breakdown on Vaccines, Autism, Food Dyes, and More

As ever, be cautious about what you hear from the Department of Health and Human Services.

Reason

Woman’s ‘Kybella’ Face Transformation Stuns People After Her Extreme Recovery Phase Goes Viral

Bored Panda contacted four dermatologists and plastic surgeons to find out more about Kybella, the FDA-approved treatment that targets the stubborn "double chin."

Bored Panda

Here are some effects of a government shutdown if Congress, Trump don't reach a deal

The U.S. government is nearing a partial shutdown, with a range of effects on public services and the broader economy

The Independent UK

2 Penny Stocks That Wall Street Believes Can Soar Over 200%

Penny stocks are highly volatile, but some of them have the potential to deliver outsized returns.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

We Got This Covered

RFK Jr. orders abortion pill ‘safety review’ based on junk science – just like his Tylenol autism claims

Guess which conservative think tank supplied the "evidence" for this one...

Benzinga

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or…

The Guardian - US

The abortion pill is safe. But why should Trump let facts get in the way?

RFK Jr is conducting a review of mifepristone, citing a deeply flawed study. The move could be devastating for women

The Guardian - UK

Pfizer sued in US over contraceptive that women say caused brain tumours

US class action lawsuit alleges company failed to warn about risks of using contraceptive injection Depo-Provera

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

3 Healthcare Stocks Using AI to Drive Growth

AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation

Grocery Coupon Guide

9 Warning Signs a Restaurant Won’t Last Due to Bad Service

A great menu can’t save a place that treats guests poorly. Service sets the tone, protects margins, and builds repeat visits. When it’s bad, costs rise, reviews crash, and regulars vanish. You notice it fast: long waits, missing items, mixed-up bills. If you care about your time and money, spotting…

The Guardian - AU

‘Anti-expert crusade’: what Trump’s hollowing out of US health institutions means for Australia

The impact of Robert F Kennedy Jr on US health organisations will affect research funding and access to medicines but may force Australia to step up, say experts

The Independent UK

What is cesium 137? FDA detects radioactive contamination in second product

Federal regulators have detected possible radioactive contamination in spices exported from Indonesia

The Guardian - US

What is leucovorin, the drug the FDA approved to treat autism?

This week the FDA approved the generic drug as a treatment for autism – a move that shocked health experts

Benzinga

Pfizer Faces Court Over Depo-Provera Brain Tumor Claims

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that could determine whether affected women can pursue their cases in court.

Benzinga

Sanofi Expands Insulin Savings Program To Cover All US Patients

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.